Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -0.35% vs 19.80% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 147.41% vs -34.88% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 7.23% vs 6.61% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -1.40% vs -14.09% in Mar 2025
Compare Profit and Loss Results of Aarey Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
472.00
168.00
304.00
180.95%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
472.00
168.00
304.00
180.95%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-4.00
7.00
175.00%
Raw Materials Consumed
450.00
37.00
413.00
1,116.22%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
49.00
-49.00
-100.00%
Operating Expenses
1.00
4.00
-3.00
-75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
19.00
-14.00
-73.68%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
465.00
125.00
340.00
272.00%
Operating Profit (PBDIT) excl Other Income
7.00
43.00
-36.00
-83.72%
Other Income
6.00
10.00
-4.00
-40.00%
Operating Profit (PBDIT)
13.00
54.00
-41.00
-75.93%
Interest
5.00
0.00
5.00
0%
Profit before Depriciation and Tax
8.00
53.00
-45.00
-84.91%
Depreciation
2.00
3.00
-1.00
-33.33%
Profit Before Taxation & Exceptional Items
5.00
50.00
-45.00
-90.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
46.00
-41.00
-89.13%
Provision for Tax
1.00
11.00
-10.00
-90.91%
Profit After Tax
3.00
34.00
-31.00
-91.18%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
57.00
162.00
-105.00
-64.81%
Profit Available for appropriations
61.00
197.00
-136.00
-69.04%
Appropriations
61.00
197.00
-136.00
-69.04%
Equity Dividend (%)
0%
207%
-207.00
Earnings Per Share
1.39
78.71
-77.32
-98.23%
Profit And Loss - Net Sales
Net Sales 472.27 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -0.35% vs 19.80% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.17 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 147.41% vs -34.88% in Mar 2025
Profit And Loss - Interest
Interest 5.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.23% vs 6.61% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 3.97 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.40% vs -14.09% in Mar 2025